Literature DB >> 18412533

Analysis of prognostic factors associated with injection-site sarcomas in cats: 57 cases (2001-2007).

Giorgio Romanelli1, Laura Marconato, Daniela Olivero, Federico Massari, Eric Zini.   

Abstract

OBJECTIVE: To identify prognostic factors in cats with injection-site sarcomas (ISSs).
DESIGN: Retrospective case series. ANIMALS: 57 cats with ISSs. PROCEDURES: Medical records of cats were reviewed with regard to sex, age, anatomic site of tumor, tumor size, histologic grade, excision of a primary tumor versus excision of a recurrent ISS, use of excision alone versus excision plus adjuvant therapy, local tumor recurrence, and development of distant metastasis to predict overall survival time (ie, time from tumor excision to death).
RESULTS: In univariate analyses, local recurrence and development of distant metastasis were significantly associated with survival time in cats. On multivariate analysis, development of distant metastasis remained a significant prognostic factor. Histologic grade was associated with distant metastasis, with cats having grade 3 tumors being significantly more likely to develop metastasis than cats with grade 1 and 2 tumors. Factors associated with local recurrence of ISSs were not identified. CONCLUSIONS AND CLINICAL RELEVANCE: The development of distant metastasis, which may occur later during the course of the disease, was identified as a prognostic factor for overall survival time in cats with ISSs. In addition, cats with histologic grade 3 ISSs should be considered for further interventional studies with chemotherapy to prevent the high rate of distant metastasis.

Entities:  

Mesh:

Year:  2008        PMID: 18412533     DOI: 10.2460/javma.232.8.1193

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  8 in total

1.  Photodynamic hyperthermal chemotherapy with indocyanine green in feline vaccine-associated sarcoma.

Authors:  Masaki Onoyama; Takeshi Tsuka; Tomohiro Imagawa; Tomohiro Osaki; Akihiko Sugiyama; Kazuo Azuma; Norihiko Ito; Kazuhiko Kawashima; Yoshiharu Okamoto
Journal:  Oncol Lett       Date:  2015-08-03       Impact factor: 2.967

Review 2.  Current knowledge on feline injection-site sarcoma treatment.

Authors:  Katarzyna Zabielska-Koczywąs; Anna Wojtalewicz; Roman Lechowski
Journal:  Acta Vet Scand       Date:  2017-07-17       Impact factor: 1.695

3.  Injection-Site Sarcoma in a Dog: Clinical and Pathological Findings.

Authors:  Terry M Jacobs; Cathy E Poehlmann; Matti Kiupel
Journal:  Case Rep Vet Med       Date:  2017-05-09

Review 4.  Vaccine-associated feline sarcoma: current perspectives.

Authors:  Corey F Saba
Journal:  Vet Med (Auckl)       Date:  2017-01-12

5.  Biological indicators of chemoresistance: an ex vivo analysis of γH2AX and p53 expression in feline injection-site sarcomas.

Authors:  Yike Bing; Zacharie Wund; Tina Abratte; Lucia Borlle; Susie Kang; Teresa Southard; Kelly R Hume
Journal:  Cancer Cell Int       Date:  2018-11-22       Impact factor: 5.722

6.  Neoadjuvant and adjuvant doxorubicin chemotherapy in a case of feline soft tissue sarcoma.

Authors:  Filippo Torrigiani; Giorgio Romanelli; Paola Roccabianca; Elisabetta Treggiari
Journal:  JFMS Open Rep       Date:  2019-07-01

7.  Combination of bleomycin and cisplatin as adjuvant electrochemotherapy protocol for the treatment of incompletely excised feline injection-site sarcomas: A retrospective study.

Authors:  Enrico P Spugnini; Bruno Vincenzi; Francesca Carocci; Chiara Bonichi; Francesco Menicagli; Alfonso Baldi
Journal:  Open Vet J       Date:  2020-07-31

8.  Origins of injection-site sarcomas in cats: the possible role of chronic inflammation-a review.

Authors:  Kevin N Woodward
Journal:  ISRN Vet Sci       Date:  2011-04-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.